Serum level of venlafaxine is associated with better memory in psychotic disorders

[1]  D. Delis,et al.  The California verbal learning test , 2016 .

[2]  Richard M. Heiberger,et al.  Statistical Analysis and Data Display: An Intermediate Course with Examples in R , 2015 .

[3]  R. Kahn,et al.  Cognitive enhancing agents in schizophrenia and bipolar disorder , 2015, European Neuropsychopharmacology.

[4]  Ming-dao Zhang,et al.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk , 2015, Neuropsychiatric disease and treatment.

[5]  J. Bodegård,et al.  Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study , 2015, Bipolar disorders.

[6]  O. Spigset,et al.  Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline , 2015, Therapeutic drug monitoring.

[7]  T. Goldberg,et al.  Antidepressants for cognitive impairment in schizophrenia — A systematic review and meta-analysis , 2014, Schizophrenia Research.

[8]  H. Akiskal,et al.  Neuropsychological performance in melancholic, atypical and undifferentiated major depression during depressed and remitted states: a prospective longitudinal study. , 2014, Journal of affective disorders.

[9]  B. Baune,et al.  Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review , 2014, Psychiatry Research.

[10]  P. Doraiswamy,et al.  Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. , 2014, The Journal of clinical psychiatry.

[11]  R. Kahn,et al.  Schizophrenia is a cognitive illness: time for a change in focus. , 2013, JAMA psychiatry.

[12]  I. Melle,et al.  Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis , 2013, Acta psychiatrica Scandinavica.

[13]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[14]  P. Cowen,et al.  The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression , 2013, Journal of psychopharmacology.

[15]  D. Carroll,et al.  Systolic blood pressure reactions to acute stress are associated with future hypertension status in the Dutch Famine Birth Cohort Study. , 2012, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[16]  Cornelius Katona,et al.  A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder , 2012, International clinical psychopharmacology.

[17]  O. Andreassen,et al.  Predictors of medication adherence in patients with schizophrenia and bipolar disorder , 2012, Acta psychiatrica Scandinavica.

[18]  Matthias J. Müller,et al.  AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. , 2014, Pharmacopsychiatry.

[19]  U. Samadani,et al.  Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice. , 2011, Journal of neurotrauma.

[20]  L. Krabbendam,et al.  Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. , 2010, The Journal of clinical psychiatry.

[21]  Golda S. Ginsburg,et al.  An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents , 2009, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[22]  E. Gudayol-Ferré,et al.  Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. , 2009, Journal of psychiatric research.

[23]  J. Tiihonen,et al.  Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial , 2009, Schizophrenia Research.

[24]  P. Buckley,et al.  Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination Therapy. , 2008, Psychiatry (Edgmont (Pa. : Township)).

[25]  Jeffrey D Dawson,et al.  Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. , 2007, The American journal of psychiatry.

[26]  C. Bundgaard,et al.  Pharmacokinetic modelling of blood–brain barrier transport of escitalopram in rats , 2007, Biopharmaceutics & drug disposition.

[27]  D. Charney,et al.  Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression. , 2007, Journal of affective disorders.

[28]  D. Romer,et al.  Suicide acceptability is related to suicide planning in U.S. adolescents and young adults. , 2007, Suicide & life-threatening behavior.

[29]  G. Debonnel,et al.  Differential physiological effects of a low dose and high doses of venlafaxine in major depression. , 2007, The international journal of neuropsychopharmacology.

[30]  René Hen,et al.  Hippocampal Neurogenesis: Regulation by Stress and Antidepressants , 2006, Biological Psychiatry.

[31]  T. Marcourakis,et al.  Cognitive performance in depressed patients after chronic use of antidepressants , 2006, Psychopharmacology.

[32]  Richard M. Heiberger,et al.  Statistical Analysis and Data Display: An Intermediate Course with Examples in S-Plus, R, and SAS , 2004 .

[33]  Eric Vermetten,et al.  Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment , 2004, Biological Psychiatry.

[34]  H. Kraemer,et al.  Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.

[35]  J. J. Ryan,et al.  Scoring Reliability on the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) , 2003, Assessment.

[36]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[37]  T. Marcourakis,et al.  Memory performance in panic disorder patients after chronic use of clomipramine , 2002, Journal of psychopharmacology.

[38]  R. Stern,et al.  Differential Impact of Executive Dysfunction on Verbal List Learning and Story Recall , 2000, The Clinical neuropsychologist.

[39]  I. Melle,et al.  Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. , 2011, Schizophrenia bulletin.

[40]  Ruben C Gur,et al.  Neurocognition in schizophrenia. , 2010, Current topics in behavioral neurosciences.

[41]  N. Cowan.  What are the differences between long-term, short-term, and working memory? , 2008, Progress in brain research.

[42]  S. Karterud,et al.  Generalizability studies of the Global Assessment of Functioning-Split version. , 2007, Comprehensive psychiatry.

[43]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.